- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05684302
The Effect of the Free-toroidal Design Lenses on the Subjective Visual Quality in the Myopic Population
January 11, 2023 updated by: Tianjin Eye Hospital
A prospective, self-control, double-blind design was conducted in Tianjin.
Two hundred participants were assigned to wear two kinds of spectacle glasses.
To examine the effect of free-toroidal design and aspherical lens on the subjective visual quality among the myopic population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A prospective, self-control, double-blind design was conducted in Tianjin.
Two hundred participants were assigned to wear two kinds of spectacle glasses.
To examine the effect of free-toroidal design and aspherical lens on the subjective visual quality among the myopic population.
The subjective visual quality of clarity and comfort were determined using a questionnaire when first wearing the glasses and after 1week.
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tianjin, China
- Tianjin Eye Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Healthy myopic people between 18 and 50 years of age
Description
Inclusion Criteria:
- health volunteers
- their spherical refraction from -0.50 to -8.00 Diopter, with the cylinder diopter less than -3.00 Diopter
- best corrected visual acuity (BCVA)≥ 20/20 in both eyes
- stable refraction (no change greater than 0.5 Diopter within two years)
Exclusion Criteria:
- if they had Aphakic or intraocular lens eyes, had a history of trauma, active eye disease or ocular surgery, serious systemic diseases, or had a wearing history of corneal contact lenses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The clarity score
Time Frame: baseline visit time
|
The clarity score by a questionnaire,scores on the questionnaire range from 1 to 6, with higher scores being better
|
baseline visit time
|
|
The comfort score
Time Frame: baseline visit time
|
The comfort score by a questionnaire,scores on the questionnaire range from 1 to 6, with higher scores being better
|
baseline visit time
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of foveal and peripheral visual acuity
Time Frame: baseline visit time
|
Accuracy of foveal and peripheral visual acuity was assessed by the eye movement tracking device
|
baseline visit time
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
December 24, 2021
Study Completion (Actual)
December 24, 2021
Study Registration Dates
First Submitted
December 24, 2022
First Submitted That Met QC Criteria
January 11, 2023
First Posted (Estimate)
January 13, 2023
Study Record Updates
Last Update Posted (Estimate)
January 13, 2023
Last Update Submitted That Met QC Criteria
January 11, 2023
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KY202101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.